I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy and safety of olokizumab in patients with rheumato..:
Genovese, Mark C
;
Fleischmann, Roy
;
Furst, Daniel
...
boreal:156549. , 2014
Link:
http://hdl.handle.net/2078.1/156549
RT Journal T1
Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study
UL https://suche.suub.uni-bremen.de/peid=base-ftunivlouvain:oai:dial.uclouvain.be:boreal:156549&Exemplar=1&LAN=DE A1 Genovese, Mark C A1 Fleischmann, Roy A1 Furst, Daniel A1 Janssen, Namieta A1 Carter, John A1 Dasgupta, Bhaskar A1 Bryson, Judy A1 Duncan, Benjamin A1 Zhu, Wei A1 Pitzalis, Costantino A1 Durez, Patrick A1 Kretsos, Kosmas PB B M J Group YR 2014 K1 Antibodies K1 Monoclonal K1 Humanized K1 Interleukin-6 K1 Male K1 Middle Aged K1 Severity of Illness Index K1 Treatment Failure K1 Treatment Outcome K1 Tumor Necrosis Factor-alpha K1 Antirheumatic Agents K1 Arthritis K1 Rheumatoid K1 Biological Products K1 Dose-Response Relationship K1 Drug K1 Double-Blind Method K1 Drug Administration Schedule K1 Female K1 Humans JF boreal:156549 LK http://hdl.handle.net/2078.1/156549 DO http://hdl.handle.net/2078.1/156549 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)